Your browser doesn't support javascript.
loading
Implementation of WHO guidelines on urine lateral flow LAM testing in high TB/HIV burden African countries.
Aguiar Soares, Kaila; Ehrlich, Joanna; Camará, Miguel; Chaloub, Souleymane; Emeka, Elom; Gando, Hervé Gildas; Ismail, Farzana; Mvusi, Lindiwe; Jele, Thulani; José, Benedita; Kgwaadira, Botshelo; Kisonga, Riziki; Letta, Taye; Liega, Aubin Oyongo; Lungu, Patrick Saili; Maama, Llang; Mahoumbou, Jocelyn; Mbendera, Kuzani; Ogoro, Jeremiah; Tollo, Daniel Alphonse Désiré; Sandy, Charles; Saye, Rufus G; Sheehama, Jacob; Musala, Sissy; Tugumisirize, Didas; Carratala, Lucia; Cossa, Marta; Garcia-Basteiro, Alberto L.
Afiliação
  • Aguiar Soares K; ISGlobal - Barcelona Institute for Global Health, Barcelona, Spain.
  • Ehrlich J; ISGlobal - Barcelona Institute for Global Health, Barcelona, Spain.
  • Camará M; Programa Nacional de Luta Contra Lepra e Tuberculose, Bissau, Guinea-Bissau.
  • Chaloub S; Guinée Médecins Sans Frontières, Conakri, Guinea.
  • Emeka E; National Tuberculosis and Leprosy Control Programme, Abuja, Nigeria.
  • Gando HG; Service de Lutte Contre la Tuberculose, Bangui, Central African Republic.
  • Ismail F; Centre for Tuberculosis, National Institute for Communicable Diseases/National Health Laboratory Services, Johannesburg, South Africa.
  • Mvusi L; TB Control and Management, National Department of Health, Pretoria, South Africa.
  • Jele T; National Tuberculosis Control Programme, Manzini, Eswatini.
  • José B; Programa Nacional de Controlo da Tuberculose, Maputo, Mozambique.
  • Kgwaadira B; Botswana National Tuberculosis Programme, Gaborone, Botswana.
  • Kisonga R; National Tuberculosis and Leprosy Programme, Dar Es Salaam, United Republic of Tanzania.
  • Letta T; National Tuberculosis and Leprosy Programme, Addis Ababa, Ethiopia.
  • Liega AO; Programme National de Lutte Contre la Tuberculose, Brazzaville, Congo.
  • Lungu PS; National Tuberculosis and Leprosy Control Programme, Lusaka, Zambia.
  • Maama L; National Tuberculosis and Leprosy Programme, Maseru, Lesotho.
  • Mahoumbou J; Programme National de Lutte Contre la Tuberculose, Libreville, Gabon.
  • Mbendera K; National Tuberculosis Control Programme, Lilongwe, Malawi.
  • Ogoro J; National Tuberculosis, Leprosy and Lung Disease Programme, Nairobi, Kenya.
  • Tollo DAD; Programme National de Lutte Contre la Tuberculose, Yaoundé, Cameroon.
  • Sandy C; Ministry of Health and Child Care, Harare, Zimbabwe.
  • Saye RG; National Leprosy and Tuberculosis Control Programme, Monrovia, Liberia.
  • Sheehama J; University of Namibia, Windhoek, Namibia.
  • Musala S; Programme National de Lutte Contre la Tuberculose, Kinshasa, Democratic Republic of the Congo.
  • Tugumisirize D; Ministry of Health - National Tuberculosis Reference Laboratory, Kampala, Uganda.
  • Carratala L; ISGlobal - Barcelona Institute for Global Health, Barcelona, Spain.
  • Cossa M; Centro de Investigação em Saúde de Manhiça (CISM), Manhiça, Mozambique.
  • Garcia-Basteiro AL; ISGlobal - Barcelona Institute for Global Health, Barcelona, Spain alberto.garcia-basteiro@manhica.net.
Eur Respir J ; 62(4)2023 10.
Article em En | MEDLINE | ID: mdl-37802630

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Infecções por HIV Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Infecções por HIV Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article